CURRICULUM VITAE

 

                                              Marie C. Gelato, M.D., Ph.D.

 

Address:

 

PO Box 504                                            Division of Endocrinology

Stony Brook, NY  11790                              Department of Medicine

                                                           HSC, T15, 060

                                                           SUNY at Stony Brook

                                                           Stony Brook, NY  11794-8154

                                                           (631) 444-1175

                                                           (631) 444-8951 (fax)

 

Personal:

 

Birth Date:                 July 7, 1947

 

Education:

 

B.A. 1969                 Hunter College, New York City, NY

                             Major:  biology.  Minor:  chemistry and sociology

 

M.S. 1971                 Michigan State University, East Lansing

                             Major:  physiology

 

Ph.D. 1975                Michigan State University, East Lansing

                             Major:  physiology. 

 

M.D. 1979                 Michigan State University, East Lansing

                             College of Human Medicine

 

Awards/Honors:

 

Mildred E. Ferguson Scholarship for Women, Michigan State University, 1976-1977

Excellence in Teaching Award, Medical School Class, Stony Brook, 1995

One of the Best Doctors in New York, New York Magazine, 2001, 2002, 2005

Chancellor’s Award for Excellence in Research, SUNY, 2002

2005 2000 Notable American Women (Tenth Commerative Edition)

2005 Who’s Who in American Medical Education

2005 Who’s Who in American Women in Science

 

 

Academic and Professional Positions:

 

1998-                      Program Director, General Clinical Research Center, SUNY at Stony Brook

 

1996-                      Professor, Department of Medicine, SUNY at Stony Brook

 

1987-1996                Associate Professor, Department of Medicine, SUNY at Stony Brook, Stony Brook, NY

 

1987-2003                Director, Metabolic Treatment Unit/Clinical Research Center, University Hospital, SUNY, Stony Brook, NY

 

1985-1987                Senior Staff Fellow, Metabolism Branch, National Cancer Institute, NIH

 

1982-1985                Medical Staff Fellow, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, NIH

 

1981-1982                Resident, Department of Medicine, UMDNJ, Rutgers University, New Jersey

 

1980-1981                Resident, Department of Medicine, Dartmouth Mary Hitchcock Medical Center, Hanover, New Hampshire

 

1979-1980                Intern, Department of Medicine, Dartmouth-Mary Hitchcock Medical Center, Hanover, New Hampshire

 

1976-1978                Graduate Assistant, Department of Human Development, College of Human Medicine

 

1975-1976                Postdoctoral Fellow, Department of Neurobiology, Max-Planck Institute for Biophysical Chemistry, Goettingen, West Germany

 

Administrative Responsibilities:

 

2005-                               Director, NIH Clinical Research Education Program

 

2004-                              Associate Program Director, Clinical Scholars Program

 

2002-2005                Member, Search Committee for Dean, School of Medicine

 

2002                        LCME Subcommittee on Research, Medical School

 

2002 -                      Member, Selection Committee, MD with Distinction in Research

 

2001-                      Academic Advisor, Third Year Medical Students

 

1998-2000                Chairperson, Appointments, Promotions and Tenure Committee, Medical School

 

1994-1996                Secondary Reviewer, Medical School Admission's Committee

 

1995                        LCME Subcommittee on Research, Medical School

 

1994                       Ad hoc Research Review Committee, Dept. of Medicine

 

1992                       Status of Women Faculty, Special Committee appointment by Dean

 

1991-1993                Medical School Admissions Committee

 

1988-                      Residency Selection Committee, Department of Medicine

 

1988-                      Residency Review Committee, Department of Medicine

 

1988-1998                 University Hospital Research Committee

 

1987-1998                Chair, Protocol Review Committee, Metabolic Treatment Unit/Clinical Research Center

 

Teaching Responsibilities:

 

1987-                      Ambulatory Care Precepting               twice weekly

                             Fellows, Residents, Nurse Practitioner

 

1988-1992                First Year Physiology                       4 hrs. lecture

 

1988-                      Second Year Pathophysiology            3 hrs. lecture

                                                                                        12.5 hrs. PPE

                                                                                        2 hrs. CPC on Pituitary Disease

 

1989-                      Physicians Assistants Course             5 hrs. lecture

 

1994-                      Clinical Pharmacology                       9 hrs. case discussions         

                             Fourth Year Selective                      

 

1994-1996                Preceptor Third Year                        6 weeks

                             Medical Student

 

1994-1996                Geriatric Fellow Research Advisor

 

1995-1998                Elective - Combined                          6 weeks        

                             Peds/Adult Endocrinology

                             Co-Coordinator with Dr. T. Wilson

Board Certification:

 

October 1979             New York State, Department of Education

May 1981                  New Jersey State of Medical Examiners

September 1982          American Board of Internal Medicine

November 1985          ABIM, Subspecialty for Endocrinology and Metabolism

 

Professional Societies:

 

GCRC Program Directors Association

Association for Patient Oriented Research

American College of Physicians

American Medical Association

Endocrine Society

American Federation for Clinical Research

Suffolk County Medical Society/Medical Society of State of New York

New York State Academy of Sciences

 

 

Ad Hoc Reviewer	Reviewer – Member
Endocrinology J Clin Endocrinol Metab Neuroendocrinology Metabolism J Clin Investigation American J Physiology NCRR/GCRC Program	NIH Study Section – AIDS (ZRG1 AARR-6) 1998-2002    Advisory Board FDA-Endocrine and Metabolic Drugs – 2000-2003 2001 NIAAA Special Emphasis Panel for FTA AA1-004-HIV 2002 NIH Special Emphasis Panel – RFA Treatment for Metabolic Complications of HIV disease 2002 NIH Pepper Center Grant Review 2002 NIH Outside Contract Proposal for an Intramural Clinical Research Center NIA 2003 NIH ZRG1ACE(02) Chairperson, Special Emphasis Panel review AARR member conflict applications 2004 NIH/NIDDK Review Panel for DERC Applications 2004 Review Panel for Fogarty Fellowships 2005 Chairperson, NIH ZRG1AAR , Special Emphasis Panel ACE member conflict applications
Editorial Board Member   2004 – JAIDS

 

Outside Committees

 

Executive Committee Member, Suffolk County Medical Society, 1998-

President, Suffolk County Medical Society, 1997-1998

Vice-President, Suffolk County Medical Society, 1996-1997

Member, AMA Advisory Panel for Physicians Practicing in a Multi-Specialty Group Practice, 1996-1998

Member, Membership Committee, Medical Society of the State of New York, 1996-1998

Treasurer, Suffolk County Medical Society, 1994-1995

Secretary, Suffolk County Medical Society, 1995-1996

Chairperson, Women Physicians Committee, Suffolk County Medical Society, 1994-1999

Delegate, Medical Society of the State of New York, 1994-2006

Council Member, American College of Physicians, 1994-1997

Member, Endocrine Society, Research Professional Activities Committee, 1995-1998

Advisory Board Member, Make-A-Wish Foundation of Suffolk County, 1989-1999

                                     FUNDING AND GRANTS PENDING

 

	Source	Project	Amount
Current
1.	NIH/NIDDK	PPAR Mediated Gene Expression in HIV Patients (PI:  M.C. Gelato)	$2,143,351 (07/01/04-06/30/08)
2.	NIH/NCRR	GCRC Grant to obtain federal funding for the Clinical Research Center at SUNY - University Hospital (PI: Norman H. Edelman) (Program Director: M.C. Gelato)	$9,806,733 (12/01/01-11/30/06)
3.	NIH/NCRR	GCRC Grant – supplement to establish an Imaging Center at Brookhaven National Laboratory as part of University Hospital GCRC (PI: Norman H. Edelman) (Program Director: M.C. Gelato)	$1,650,000 (06/01/03-11/30/06)
4.	Glaxo Smith Kline	Gene Expression in HIV Lipodystrophy before and after treatment with Rosiglitazone PI:  Gelato, M.C.	$70,000 (11/01/02-8/31/04)
5.	New York State	Empire State Clinical Research Fellowship Award Mentor:  M.C. Gelato	$120,000 (07/01/03-06/30/05)
	NIH/ NCCAM	A Novel Therapy for Glucose Intolerance in HIV Disease    PI: M.C. Gelato	$250,000 (07/01/05-06/30/09)
Past
1.	National Institutes of  Health	Cellular Mechanisms of Metabolic Dysfunction in HIV Disease (PI: M.C. Gelato)	$1,775,947 (09/01/99-08/31/03) (no cost extension)
2.	Multiple Sponsors	Geriatric Endocrinology Research (PI: M.C. Gelato)	$5,000 (05/01/95-12/30/97)
3.	AMFAR American Federation for AIDS Research	HIV Lipodystrophy and Altered Adipose Phenotype (PI:  D.C. Mynarcik; Co-PI:  M.C. Gelato)	$70,000 (05-31-00-12/31/01)
4.	National Institutes of Health	Cellular Mechanisms for Sarcopenia in the Elderly (Co-PI:  M.C. Gelato)	$1,843,750 (07/01/01-06/30/06)
5.	National Institutes of Health	Cytokine Regulation of IGF System During Infection (PI: C.H. Lang; Co-PI: M.C. Gelato)	$1,454,367 (04/01/96-03/31/00)
6.	National Institutes of  Health	Muscle Protein Synthesis and GH/IGF Axis (PI: M.C. Gelato)	$946,778.86 (09/30/94-08/31/98)
7.	National Research Service Award	Role of Insulin-like Growth Factors in Metabolic Diseases (Fellow: R.A. Frost; Sponsor: M.C. Gelato)	$26,708/yr (03/01/94-04/01/97)
8.	Merck Research Laboratories	Double-Blind, Placebo-Controlled, Parallel Multiple Oral Dose Pilot Study of MK-0677 in Musculoskeletally Impaired Elderly (PI: M.C. Gelato)	$99,432 (03/16/95-03/15/96)
9.	Serono Laboratories, Inc.	GH and Immune Function in the Elderly (PI: M.C. Gelato)	$10,000 (11/01/93-12/06/95)
10.	Hoffman La Roche, Inc.	GHRH Physiology (PI: M.C. Gelato)	$75,000 (06/01/89-06/11/94)
11.	Diabetes Treatment Centers of America	Tissue Specific Regulation of Insulin-like Growth-I (PI: M.C. Gelato)	$50,000 (03/01/90-08/31/92)
12.	NSF ROW Career Advancement Award	IGFs in the Developing Hippocampus (PI: M.C. Gelato)	$13,308 (08/01/90-01/31/92)
13.	Diabetes Research and Education Foundation	The IGF-I System in the Zucker Fatty Rat (PI: M.C. Gelato)	$18,000 (06/30/91-12/31/92)
14.	National Institutes of Health	The Effects of Chronic Hypoxemia on Insulin-like Growth Factors in Fetal Sheep (Co-investigator Center Grant Columbia University) (PI: Salha Daniels; Co-PI: M.C. Gelato)	$15,000 (03/01/91-06/30/94)
15.	New York Obesity Research Center	The IGF-I system in the Zucker Fatty Rat (PI: M.C. Gelato)	$15,000 (01/01/92-12/31/92)
16.	AmGen, Inc.	Effects of Erythropoietin on the Endocrine System (PI: H.E. Carlson)	$34,000 (01/01/92-12/31/93)
17.	BRSC	GH and Immune Function in the Elderly (PI: M.C. Gelato)	$7,830 (08/01/93-08/31/94)
18.	American Heart Association NYS Affiliate Fellowship	Insulin-like Growth Factor-I Effects on Cardiomyocytes (Fellow: R.A. Frost; Sponsor: M.C. Gelato)	$30,000 (07/01/94)

 

 

                                                           PUBLICATIONS

 

                                              Marie C. Gelato, M.D., Ph.D.

 

1)     W. Wuttke, M. Gelato, and J. Meites.  Mechanisms of Pentobarbital Actions on Prolactin Release.  Endocrinology 89:1191-1194, 1971.

 

2)     M. Gelato, S. K. Quadri, and J. Meites.  Inhibition of Prolactin Release by a Thalidomide-Related Compound (CG-603).  Proc. Soc. Exp. Biol. Med. 140:167168, 1972.

 

3)     L. Grandison, M. Gelato, and J. Meites.  Inhibition of Prolactin Secretion by Cholinergic Drugs.  Proc. Soc. Exp. Biol. Med. 145:1236-1239, 1974.

 

4)     M. Gelato, S. Marshall, M. Boudreau, J. Bruni, G.A. Campbell, and J. Meites.  Effects of Thyroid and Ovaries on Prolactin Binding Activity in Rat Liver.  Endocrinology 96:1292-1296, 1975.

 

5)     S. Marshall, M. Gelato, and J. Meites.  Serum Prolactin Levels and Prolactin Binding Activity in Adrenals and Kidneys of Male Rats after Dehydration, Salt Loading, and Unilateral Nephrectomy.  Proc. Soc. Exp. Biol. Med. 149:185-188, 1975.

 

6)     M. Gelato and W. Wuttke.  Evidence for a Positive Feedback Action of Estrogen on LH Secretion in Immature Female Rats.  IRCS Med Sci 3:260, 1975.

 

7)     S. Marshall, G.S. Kledzik, M. Gelato, G.A. Campbell, and J. Meites.  Effects of Estrogen and Testosterone on Specific Prolactin Binding in the Kidneys and Adrenals of Rats.  Steroids 27:187-195, 1976.

 

8)     M. Gelato, J. Dibbet, S. Marshall, J. Meites, and W. Wuttke.  Prolactin-Adrenal Interaction in the Immature Female Rat.  Ann. Biol. Anim. Bioch. Biophys. 16:395-401, 1976.

 

9)     W. Wuttke and M. Gelato.  Maturation of Positive Feedback Action of Estradiol and Its Inhibition by Prolactin in Female Rats.  Ann. Biol. Anim. Bioch. Biophys. 16:349-359, 1976.

 

10)  W. Wuttke, K.D. Dohler, and M. Gelato.  Oestrogens and Prolactin as Possible Regulators of Puberty.  J. Endocrinology 63:391-396, 1976.

 

11)  W. Beck, S. Engelbart, M. Gelato, and W. Wuttke.  Antigonadotrophic Effect of Prolactin in Adult Castrated and in Immature Female Rats.  Acta Endocrinol.  84:62-71, 1977.

 

12)  M. Gelato, J. Meites, and W. Wuttke.  Adrenal Involvement in the Timing of Puberty in Female Rats:  Interaction with Serum Prolactin Levels.  Acta Endocrinol. 89:590-598, 1978.

 

13)  J.L. Borges, R.M. Blizzard, M.C. Gelato, R.F. Furlanetto, A.D. Rogol, W.S. Evans, M.L. Vance, D.L. Kaiser, R. M. MacLeod, G.R. Merriam, D.L. Loriaux, J. Spiess, J. Rivier, W. Vale, and M.O. Thorner.  Effects of Human Pancreatic Tumor Growth Hormone Releasing Factor on Growth Hormone and Somatomedin-C Levels in Patients with Idiopathic Growth Hormone Deficiency.  Lancet ii:119-124, 1983.

 

14)  M.C. Gelato, O.H. Pescovitz, F. Cassorla, D.L. Loriaux and G.R. Merriam.  Effects of a Growth Hormone Releasing Factor in Man.  J. Clin. Endocrinol. Metab. 57:674-676, 1983.

 

15)  M.C. Gelato, O.H. Pescovitz, F. Cassorla, D.L. Loriaux and G.R. Merriam.  Dose-Response Relationships for the Effects of Growth Hormone-Releasing Factor-(l-44)-NH2 in Young Adult Men and Women.  J. Clin. Endocrinol. Metab. 59:197-201, 1984.

 

16)  R. D'Agata, F. Cassorla, A.K. Munabi, V. Mercq, M.C. Gelato, B.D. Albertson and D.L. Loriaux.  Direct Effect of the Luteinizing Hormone Releasing Hormone Analog D-TRP6-Pro6-Net-LHRH on Rat Testicular Steroidogenesis.  Steroids 43:201-207, 1984.

 

17)  A.K. Munabi, V. Mericq, M. Koppelman, M.C. Gelato, B.D. Albertson, D.L. Loriaux and F. Cassorla.  The Effects of Prolactin on Rat Ovarian Steroidogenic Activities.  Steroids 43:631-638, 1984.

 

18)  M.C. Gelato, G.R. Merriam, M.L. Vance, J.A. Goldman, C. Webb, W.S. Evans, J. Rock, E.A. Oldfield, M.E. Molitch, J. Rivier, W. Vale, S. Reichlin, L.A. Frohman, D.L. Loriaux and M.O. Thorner.  Effects of Growth Hormone-Releasing Factor upon Growth Hormone Secretion in Acromegaly.  J. Clin. Endocrinol. Metab. 60:251-257, 1985.

 

19)  A.K. Munabi, V. Mericq, M.C. Gelato, M.C.S. Koppelman, B.D. Albertson, D.L. Loriaux, F. Cassorla.  The Effects of Prolactin on Rat Testicular Steroidogenic Enzyme Activities.  Hormone and Metabolic Research 17:47-48, 1985.

 

20)  M.C. Gelato, R.S. Rittmaster, O.H. Pescovitz, M. Caruso Nicoletti, W.E. Nixon, R. D'Agata, D. Lynn Loriaux, and G.R. Merriam.  Growth Hormone Responses to Continuous Infusions of Growth Hormone-Releasing Hormone.  J. Clin. Endocrinol. Metab. 61:223-238, 1985.

 

21)  M.C. Gelato, J. Levine Ross, S. Malozowski, O.H. Pescovitz, M. Skerda, F. Cassorla, D. Lynn Loriaux, G.R. Merriam.  Effects of Pulsatile Administration of Growth Hormone-Releasing Hormone on Short-term Linear Growth in Children with Growth Hormone Deficiency.  J. Clin. Endocrinol. Metab. 61:444-450, 1985.

 

22)  S. Malozowski, F. Cassorla, M. Gelato, M. Nicoletti, R. R'Agata, V. Vericq, D.L. Loriaux.  Direct Effect of the Luteinizing Hormone Releasing Hormone Analog D-Trp9-Net-LHRH on Rat Ovarian Steroidogenesis.  Hormone and Metabolic Research 7:321-322, 1985.

 

23)  Merriam GR, Gelato MC, Avgierino P, Blackman M, Cassorla F, Harman M, Loriaux DL, Malozowski S, Muzzo S. Nicoletti MC, Oldfield E, Pavlow E, Pescovitz O, Sobieszczyk S, Winterer J.  Application of Growth Hormone-Releasing Hormone in Diagnosis and Therapy.  Neuroendocrinology Letters, Vol 7:102, 1985.

 

24)  E.P. Pavlov, S. Mitchell Harman, G.R. Merriam, M.C. Gelato, M.R. Blackman.  Responses of Growth Hormone and Somatomedin-C to Growth Hormone Releasing Hormone in Healthy Aging Men.  J. Clin. Endocrinol. Metab. 62:595-600, 1986.

 

25)  M.C. Gelato, S. Malozowski, M. Caruso Nicoletti, J. Levine Ross, O.H. Pescovitz, S. Rose, D.L. Loriaux, F. Cassorla and G.R. Merriam.  Growth Hormone Responses to Growth Hormone-Releasing Hormone During Pubertal Development in Normal Boys and Girls: Comparison to Idiopathic Short Stature and Growth Hormone Deficiency.  J. Clin. Endocrinol. Metab. 63:174-179, 1986.

 

26)  A.G. Palestine, C. Mullenburg - Columbre, M. Kim, M.C. Gelato, R.B. Nussenblat.  Bromocriptine and Low Dose Cyclosporine in the Treatment of Experimental Autoimmune Uveitis.  J. Clin. Investigation 79:1078-1081, 1987.

 

27)  O.H. Pescovitz, M.C. Gelato, M. Bundy, D.L. Loriaux, G.R. Merriam, M.D. Pescovitz.  Production of Monoclonal Antibodies Against Human Growth Hormone-Releasing Hormone and Their Use in an Enzyme Linked Immunoabsorbent Assay (ELISA).  J. Immunological Methods 94:257-262, 1986.

 

28)  W. Kiess, S. Malozowski, M. Gelato, O. Butenandt, H. Doerr, B. Crisp, E. Eisl, A. Maluish, G. Merriam, B.H. Belohradsky.  Lymphocyte Subset Distribution and Natural Killer Activity in Growth Hormone Deficiency Before and During Treatment with Growth Hormone-Releasing Hormone.  Clin. Immunology and ImmunoPathology 48:85-94, 1988.

 

29)  M.C. Gelato, W. Kiess, L. Lee, S. Malozowski, M.M. Rechler, S. P. Nisley.  The Insulin-like Growth Factor-II/Mannose-6-Phosphate Receptor is Present in Monkey Serum.  J. Clin. Endocrinol Metab 67:669-675, 1988.

 

30)  S.R. Rose, M. Kibarian, M. Gelato, J. Levine-Ross, J. Muellner, K. Gay, G.R. Merriam, G. Cutler, F. Cassorla.  Brief Administration of Sex Steroid Increases the Mean Twenty-Four Hour Growth Hormone Plasma Level in Children with Idiopathic Short Stature.  J. Pediatric Endocrinol 3:1-5, 1988.

 

31)  M.C. Gelato, D.L. Loriaux, G.R. Merriam.  Growth Hormone Responses to Growth Hormone-Releasing Hormone in Patients with Hand Schuller Christian Disease: A Hypothalamic Model of Growth Hormone Deficiency.  Neuroendocrinology 50:259-264, 1989.

 

32)  32) M.C. Gelato, C. Rutherford, R.I. Stark and S.S. Daniels.    The Insulin-like Growth Factor-II/Mannose-6-Phosphate Receptor is Present in Fetal and Maternal Sheep Serum.   Endocrinology 124:2935-2943, 1989.

 

33)  W. Kiess, M. Gelato, P. Nissley.  The Serum Insulin-like Growth Factor-II/Mannose-6-Phosphate Receptor.  Insulin-like Growth Factor Binding Proteins. S.L.S. Drop, R.L. Hintz, editors. Elsevier Press, 1989. p. 197-202.

 

34)  D. Olchovsky, J.F. Bruno, T.L. Wood, M.C. Gelato, J.M. Gilbert, M. Berelowitz.  Altered Pituitary Growth Hormone Regulation in Streptozotocin-Diabetic Rats: A Combined Defect of Hypothalamic Somatostatin and Growth Hormone-Releasing Factor.  Endocrinology 126:53-61, 1990.

 

35)  M.C. Gelato, E. Oldfield, D.L. Loriaux, G.R. Merriam.  Pulsatile Growth Hormone Secretion During Continuous Infusions of Growth Hormone-Releasing Hormone in Patients with Acromegaly and Normal Adult Men.  J. Clin. Endocrinol. Metab. 71:585-590, 1990.

 

36)  M.C. Gelato, L.A. Gaynes, L.A. Greenstein, S.P. Nissley.  Heterogeneity of Binding Sites Within the Large Growth Hormone Dependent Binding Protein in Human Serum.  J Clin Endo Metabol 70:879-887, 1990.

 

37)  M. Gelato, J. Vassalotti.  Insulin-like Growth Factor-II: A Possible Growth Factor for Pheochromocytoma.  J. Clin. Endocrinol. Metab. 71:1168-1174, 1990.

 

38)  S. Muzzo, R. Burrows, J. Winterer, I. Young, S Malozowski, M. Gelato, F. Cassorla, G. Merriam.  The Growth Hormone Response to Growth Hormone-Releasing Hormone Stimulation in Infantile Protein-Caloric Malnutrition.  Nutrition Research 10:1073-1076, 1990.

 

39)  S. Malozowski, F. Cassorla, G.R. Merriam, M.C. Gelato.  Pulsatile Growth Hormone (GH)-Releasing Hormone (GHRH) Treatment Induces a Response in Some GH Deficient Patients Initially Unresponsive to a Single GHRH Bolus. J. Ped. Endocrinol. 4:1-5, 1991.

 

40)  T.L. Wood, M. Berelowitz, M. Gelato, C. Roberts, Jr., D. LeRoith, M.M. Rechler, W. Mallard, J.S. McKelvy.  Hormonal Regulation of Rat Hypothalamic Neuropeptide mRNAs: Effect of Hypophspectomy and Hormone Replacement on GRF, SRIF, and the Insulin-like Growth Factors, Neuroendocrinology 52:298-305, 1991.

 

41)  D. Olchovsky, MC Gelato, JF Bruno, Jinfen Song, M Berelowitz.  Pituitary IGF-I Content and Gene Expression in the Streptozotocin Diabetic Rat: Evidence for Tissue Specific Regulation Endocrinology  128:923-928, 1991.

 

42)  E. Spatola, O. Pescovitz, K. Marsh, N. Johnson, S. Berry, M. Gelato.  Interaction of Growth Hormone-Releasing Hormone with the Insulin-like Growth Factors during Prenatal Development in the Rat. Endocrinology  129:1193-1200, 1991.

 

43)  M.C. Gelato, J. Vassalotti, E. Spatola, C. Rutherford, K. Marsh, H.E. Carlson.  Differential Tissue Regulation of the Insulin-like Growth Factors in Rats Bearing the MStT/W15 Pituitary Tumor.  Neuroendocrinology 56: 765-774, 1992.

 

44)  M. Gelato, D. Alexander, K. Marsh.  Differential Tissue Regulation of Insulin-like Growth Factor (IGF)-Binding Proteins (BPs) in Experimental Diabetes Mellitus in the Rat.  Diabetes 41: 1511-1519, 1992.

 

45)  M.C. Gelato, G. San Roman, C. Rutherford, S. Schmoys, A. Monheit. The Circulating Insulin-like Growth Factor-II/Mannose-6-Phosphate Receptor in Pregnancy of Normal and Diabetic Women. Metabolism 42:1031-1038, 1993.

 

46)  D. Olchovsky, J. Song, M.C. Gelato, E. Spatola, J.F.Bruno, M. Berelowitz. Pituitary and Hypothalamic Insulin-like Growth Factor-I (IGF-I) and IGF-I Receptor Expression in Food-deprived Rats. Mol.Cell. Endocrinology 93:193-198, 1993.

 

47)  H. Tsu Kahara, D.V. Gordienko, M.C. Gelato, M.S. Goligorsky. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney International 45:598-604, 1994.

 

48)  J. Fan, P.E. Molina, M.C. Gelato, G.H. Lang. Differential tissue regulation of insulin-like growth factor I content and binding proteins after endo toxin.  Endocrinology 134:1685-1692, 1994.

 

49)  R. Frost, C.H. Lang, A. Bereket, M.C. Gelato.  Insulin-like  Growth Factor (IGF)-Binding Protein (BP) -1 is Phosphorylated in the Serum of Catabolic Patients. J.Clin.Endocrinology and Metabolism 78:1533-1535, 1994.

 

50)  A. Bereket, C.H. Lang, S.L. Blethen, M.C. Gelato, J. Fan, R.A. Frost, T.A. Wilson. Effect of Insulin on the IGF System in Children With New Onset Insulin Dependent Diabetes Mellitus. J. Clin. Endocrinol. Metab. 80:1312-1317, 1995.

 

51)  J.Fan, D. Char, A.J. Kulasa, W. Pan, S.R. Maitra, C.S. Patlak, Z. Spolarics, M.C. Gelato, C.H. Lang. Alterations in Hepatic Production and Peripheral Clearance of IGF-I After Endotoxin.  Amer. J. Physiology 269:E33-E42, 1995.

 

52)  M. Wojnar, J. Fan, R.A. Frost, M.C. Gelato, C.H. Lang. Alterations in the Insulin-Like Growth Factor System in Trauma Patients. Am. J. Physiol. 268:R970-77, 1995.

 

53)  H.E. Carlson, M.L. Graber, M.C. Gelato, J.M. Hershman.  Endocrine Effects of Erythropoietin. Int. Journal of Artificial Organs. Int'l. J. American Organs. 18:301-314, 1995.

 

54)  J. Fan, P.E. Molina, M.C. Gelato, C.H. Lang. Regulation of Insulin-like Growth Factor I Content and Binding Proteins by Tumor Necrosis Factor. Amer. J. Physiol. 269:R1204-R1212, 1995.

 

55)  J. Fan, D. Char, G.J. Bagby, M.C. Gelato, C.H. Lange.  Regulation of Insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor.  Amer. J. Physiol. 269:R1204-R1212, 1995.

 

56)  M.M. April, A. Heimann, L.U. Jung, M.C. Gelato. Follicular Variant of Papillary Carcinoma With Hyperthyroidism. J. Otolaryngology-Head and Neck Surgery. 113:628-631, 1996.

 

57)  P.E. Molina, J. Fan, M.C. Gelato, C.H. Lang, N.N. Abumrad. Hormone-independent Modulation of Insulin-like Growth Factor-I: A Specific Role for Vitamin B1 (Thiamine). Nutritional Biochemistry. 7:207-213, 1996.

 

58)  R.A. Frost, J. Fuhrer, P. Mariuz, C.H. Lang, M.C. Gelato. Wasting in the Acquired Immune Deficiency Syndrome is Associated with Multiple Defects in the Serum Insulin-Like Growth Factor System. Clin.Endocrinol. 44:501-514, 1996.

 

59)  R.A. Frost, S. A. Nachman, C.H. Lang, M.C. Gelato. Proteolysis of Insulin-like Growth Factor Binding Protein-3 in HIV-Positive Children Who Fail to Thrive. J. Clin. Endocrinol. Metab. 81:2957-2962, 1996.

 

60)  S. Castells, I. Beaulieu, C. Torrado, K.E. Wisniewski, S. Zarny, M.C. Gelato. Hypothalamic Versus Pituitary Dysfunction in Down Syndrome as Cause of Growth Retardation. J of Intellectual Disability Research. 40:802, 1996.

 

61)  B. Samstein, M.L. Haimis, J. Fan, R.A. Frost, M.C. Gelato, C.H. Lang. IL-6 Stimulation of Insulin-like Growth Factor Binding Protein (IGFBP-1) Production. BBRC 228:611-615, 1996.

 

62)  A. Bereket, T.A. Wilson, S.L. Blethen, J. Fie, R.A. Frost, M.C. Gelato, C.H. Lang.  Effect of Short-Term Fasting on Free/Dissociable IGF-I Concentrations in Normal Human Serum.  J. Clin. Endocrinol. Metab. 81:4379-4384, 1996.

 

63)  C.H. Lang, J. Fan, R.A. Frost, M.C. Gelato, Y. Sakurai, D.N. Herndon, R.R. Wolfe.  Regulation of the Insulin-like Growth Factor System by Insulin in Burn Patients. J. Clin. Endocrinol. Metab. 81:2474-2480, 1996.

 

64)  C.H. Lang, V. Pollard, J. Fan, L.D. Traber, D.L. Traber, R.A. Frost, M.C. Gelato, D.S. Prough.  Acute Alterations in Growth Hormone-Insulin-Like Growth Factor Axis in Humans Injected with Endotoxin. American J. Physiology 273:R371-378, 1997.

 

65)  R.A. Frost, C.H. Lang, M.C. Gelato.  Transient Exposure of Human Myoblasts to Tumor Necrosis Factor a Inhibits Serum Synthesis. Endocrinology 38:4153-59, 1997.

 

66)  M.A. McNurlan, P.J. Garlick, K.A. DeCristofaro, R.A. Frost, C.H. Lang, R.W. Johnson, A.M. Santasier, C.J. Cabahug, R.T. Steigbigel, J. Fuhrer, M.C. Gelato.  Responsiveness of Muscle Protein Synthesis to Growth Hormone Administration in HIV-Infected Individuals Declines with Severity of Disease.  J. Clinical Investigation 100:2125-2132, 1997.

 

67)  M.A. McNurlan, P.J. Garlick, R.A. Frost, K.A. DeCristofaro, C.H. Lang, R.T. Steigbegel, J. Fuhrer, M.C. Gelato.  Albumin and Bone Collagen Synthesis in HIV+ Subjects:  Differential Effects of Growth Hormone Administration.  J. Clin. Endocrinol. Metab. 83:3050-3055, 1998.

 

68)  D.C. Mynarcik, R.A. Frost, C.H. Lang, K. DeCristofaro, M.A. McNurlan, P.J. Garlick, R. Steigbigel, J. Fuhrer, M.C. Gelato.  The Insulin-like growth factor system in HIV disease:  effects of growth hormone administration.  J. of Acquired Immune Deficiency Syndromes.  Vol. 22, p. 49-55, 1999.

 

69)  D.C. Mynarcik, M. McNurlan, R.T. Steigbigel, J. Fuhrer, M.C. Gelato.  Association of Severe Insulin Resistance with Both Loss of Limb Fat and Elevated Serum Tumor Necrosis Factor Receptor Levels in HIV Lipodystrophy.  JAIDS 25:312-21, 2000.

 

70)  G. Caso, P.J. Garlick, M.C. Gelato, M.A. McNurlan.  Lymphocyte protein synthesis is increased with progression of HIV disease to AIDS.  Clinical Science 101:583-589, 2001.

 

71)  Grinspoon, S. and Gelato, M.C.  The rationale use of growth hormone in HIV-infected patients.  J Clin Endocrin Metabol 86:3478-3479, 2001.

 

72)  M.C. Gelato, D.C. Mynarcik, M. McNurlan.  Soluble TNF-A Receptor-2, A Serum Marker of Growth Hormone Resistance in Subjects with HIV Disease.  Clinical Science 102:85-90, 2002.

 

73)  Gelato, M.C., Mynarcik, D., Quick, J.L., Steigbigel, R.T., Fuhrer, J., Brathwaite, C.E.M., Brebbia, J.S., Wax, M.R., and McNurlan, M.  Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone:  a pilot study.  JAIDS.  31:163-170, 2002.

 

74)  Mynarcik, D., Combs, T., McNurlan, M.A., Scherer, P.E., Gelato, M.C.  Acrp30 and Leptin Levels in HIV-infected Subject with Insulin Resistance and Body Fat Redistribution.  JAIDS.  31:514-520, 2002.

 

75)  S.A. Kho, L.K. Nieman, M.C. Gelato.  Cushing’s Disease After Surgery and Radiation Therapy for Non Functioning Pituitary Adenoma.  Endocrine Practice 8:4-8, 2002.

 

76)  Gelato, M.C.  Insulin and carbohydrate dysregulation.  Clin Invest Dis 36:S91-95, 2003.

 

77)  Mynarcik, D.C., Wei L-X, Komaroff, E., Ferris, R., McNurlan, M.A., Gelato, M.C.  Chronic loss of subcutaneous adipose tissue in HIV-associated lipodystrophy may not be associated with accelerated apoptosis.  JAIDS 38:367-71, 2005.

 

78)  Mynarcik, D.C., McNurlan, M.A., Komaroff, E, Gelato M.C. Endothelial Adhesion Molecules Are Associated with inflammation in Subjects with HIV Disease. JAIDS submitted.

 

79)  Caso, G., Vosswinkle,J.A., Ballou, L.A., garlick, P.J., Gelato, M.C., McNurlan, M.A. Effect Of eating On Muscle protein Synthesis In healthy Volunteers: A comparison Of The Constant Infusion And Flooding Techniques. AJP, in press.

 

80)  Feiner, J., Ferris, R., Mynarcik, D.,McNurlan, M.A., Gelato, M.C. The Effects Of Chromium Picolinate On Insulin Sensitivity in HIV+  Patients: A pilot Study.  JAIDS, submitted.

 

 

 

 

                                                  INVITED CHAPTERS

 

                                              Marie C. Gelato, M.D., Ph.D.

 

1)     W. Wuttke, M. Gelato, and J. Meites.  Effects of Na-Pentobarbital on Hypothalamic PIF, LRH, and FSH-RF and on Serum Prolactin, LH and FSH. Brain-Endocrine Interaction.  Median Eminence: Structure and Function. Int. Symp. Munich 1971, p. 267-79 (Karger, Basel, 1972).

 

2)     M.C. Gelato and G.R. Merriam.  Growth Hormone Releasing Hormone.  Annual Review of Physiology, Vol. 48, 1986.

 

3)     M.O. Thorner, W.S. Evans, M.L. Vance, R.M. Blizzard, A.D. Rogol, D.L. Kaiser, A. Johanson, L.A. Frohman, J.L. Thominet, R. Fulanetto, M. Gelato, G.R. Merriam, J.H. Goldman, S. Reichlin, J. Rivier and W. Vale.  Growth Hormone Releasing Factor.  Human Growth Hormone Conference, Chapter 27, p. 361-372. eds. S. Raiti and R.T. Tolman, Plenum Medical Book Co., 1986.

 

4)     M. Gelato, S. Malozowski, O.H. Pescovitz, F. Cassorla, D.L. Loriaux and G.R. Merriam.  Growth Hormone-Releasing Hormone: Therapeutic Perspectives.  Pediatrician 14:162-167, 1987.

 

5)     M. Gelato, S. Malozowski, M. Caruso-Nicoletti, O.H. Pescovitz, D.L. Loriaux, F. Cassorla, and G.R. Merriam.  Evaluation and Treatment of Growth Hormone Deficiency with Growth Hormone Releasing Hormone. In:  Disorders of Human Growth, Advances in Research and Treatment.  Eds. Gilman Grave, Fernando Cassorla, Charles Thomas, Illinois, 1988, pp. 37-56. 

 

6)     Merriam, G. R., Ho K.Y., Evans W.S., Thorner M.O., Pavlov E., Harman S. M., Blackman M., Rose S.R., Gelato M.C. Cassorla F., Liu L., Sherins R.J. Effects of Sex Steroids on Episodic Growth Hormone Secretion.  In: Endocrine Biorhythms. M. Filicori (Ed.), Rome, CIS Press, 1988, pp.212-225.

 

7)     M.C. Gelato. Growth Hormone/Insulin-like Growth Factor-I and Immune Function. Trends in Endocrinology and Metabolism 4:106-110, 1993.

 

8)     M.C. Gelato. Growth Hormone-Releasing Hormone.  The Endocrinologist, Volume 4, pg. 64-68, 1994.

 

9)     M.C. Gelato, M. Berelowitz. Insulin-like Growth-Factor-I and Insulin-Like Growth Factor Binding Proteins in the Zucker Fatty Rat: A Case for Differential Tissue Regulation. In: Current Directions in Insulin-Like Growth Factor Research. eds. D. LeRoith and M.K. Raizada. Plenum Press, pg. 387-396, 1993.

 

10)  P. Manasco, D. Blithe, S. Rose, M.C. Gelato, J.A. Magner, B.C. Nisula. Thyrotropin Abnormalities in Central Hypothyroidism.  In: Glycoprotein Hormones eds. J.W. Lustbader, D. Puett, R.W. Ruddon, Springer-Verlag, N.Y., pg. 343-348, 1994.

 

11)  M.C. Gelato, M.T. Sheehan. Growth Hormone Relationships to Immune Function in Humans. In:  Growth Hormone Secretagogues ed. B. Bercer and R. Walker.  Chapter 25, pg. 433-441, Springer-Verlog, N.Y., 1996.

 

12)  M.C. Gelato. Aging and Immune Function: A Possible Role for Growth Hormone. Hormone Research. 45:46-49, 1996.

 

13)  M.C. Gelato, R.A. Frost. IGFBP-3: Functional and Structural Implications in Aging and Wasting Syndromes.  NIH Conference on Aging.  Endocrine 7:81-85, 1997.

 

14)  P.J. Garlick, M.A. Mc Nurlan, T. Bark, C.H. Lang, M.C. Gelato.  Hormone Sensitivity of Protein Metabolism in Relation to Nutrition and Disease. J. Nutr. (in press).

 

15)  M.C. Gelato.  The Growth Hormone/Insulin-Like Growth Factor Axis in Critical Illness.  J Pediatric Endocrine Metab. 13:1023-29, 2000.

 

16)  M.C. Gelato.  Growth Hormone Releasing Hormone/Revisited. The Endocrinologist. 15: 159-164, 2005.

 

 

                                                           ABSTRACTS

 

Marie C. Gelato, M.D., Ph.D.

 

1)     M.C. Gelato, K.H. Lu, and J. Meites.  Inhibition of luteolysis by Iproniazid During the Estrous Cycle in Rats.  Proc. from the Fifth Annual Meeting of the Society for the Study of Reproduction.  Abstract No. 109:80, 1972.

 

2)     M.C. Gelato, J. Rock, J. Borges, E. Oldfield, W. vale, D.L. Loriaux, M.O. Thorner, and G.R. Merriam.  Growth Hormone Releasing Factor Stimulation of Growth Hormone in Acromegaly.  XIV ACTA Endocrinologica Congress.  Abstract No. 128:71, 1983.

 

3)     M.C. Gelato, J. Levine Ross, O. Pescovitz, F. Cassorla, D.L. Loriaux, and G. Merriam.  Growth Hormone Releasing Factor Administration to Children with Growth Hormone Deficiency.  (presented at Growth Hormone Symposium, Baltimore, MD, Nov, 1983).

 

4)     M.C. Gelato, O. Pescovitz, F. Cassorla, D.L. Loriaux and G.R. Merriam.  Dose-Response Relationships for Effects of Growth Hormone-Releasing Factor l-44 NH2 (GRF-44) in Men and Women: Development of a GRF Stimulation Test. Clin. Res. 32:265A, 1984.

 

5)     M.C. Gelato, J. Levine Ross, O. Pescovitz, F. Cassorla, M. Skerda, P. Feuillian, D.L. Loriaux and G.R. Merriam.  Acceleration of Linear Growth After Repeated Doses of Growth Hormone-Releasing Factor (GRF).  Ped Res 19:167A, 1984.

 

6)     A.K. Munabi, V. Mericq, M.C. Gelato, S. Malozowski, R. D'Agata, M.M. Koppelman, B.D. Albertson, F. Cassorla and D.L. Loriaux.  The Effects of Prolactin (PRL) on Rat Testicular Steroidogenic Enzyme Activities.  7th Int. Cong. Endocrinology. Abst. No. 2114. 1322, 1984.

 

7)     R. D'Agata, A.K. Munabi, V. Mericq, M.C. Gelato, B.D. Albertson, D.L. Loriaux and F. Cassorla.  Direct Effect of the GnRH Analog D-Trip6-Pro9-Net-GnRH on Rat Testicular Steroidogenesis.  7th Int. Cong. Endocrinology. Abst. No. 802:661, 1984.

 

8)     O.H. Pescovitz, W.E. Nixon, M.C. Gelato, M. Pescovitz, D.L. Loriaux and G.R. Merriam.  Growth Hormone-Releasing Factor (GRF) Therapy of Growth Hormone Deficiency:  Measurement of Antibodies to GRF by Enzyme-Linked Immunoabsorbent (ELISA) Techniques.  7th Int. Cong. Endocrinology. Abt. No. 1791-1156, 1984.

 

9)     E.P. Pavlov, G.R. Merriam, M.C. Gelato, S.M. Harman, and M.R. Blackman.  Responses of Growth Hormone and Somatomedin-C to Growth Hormone Releasing Factor l-44 NH2 (GRF-44) in Healthy Aging Men.  Clin. Res. 32:639A, 1985.

 

10)  G.R. Merriam, M.C. Gelato, O. Pescovitz, F. Cassorla, E.Oldfield, R. Green, and D.L. Loriaux.  Growth Hormone Releasing Factor Test: Dose-Response, Safety, and Applications.   5th Winter Neuropeptide Conference, 20 January 1984.

 

11)  M.C. Gelato, R. D'Agata, O. Pescovitz, D.L. Loriaux, and G.R. Merriam.  Effects of Continuous Infusions of Growth Hormone-Releasing Factor on GH in Men.  Ital. Endoc. Soc., 7 May 1984.

 

12)  M.C. Gelato, O. Pescovitz, W. Nixon, R. D'Agata, F. Cassorla, D.L. Loriaux, and G.R. Merriam.  Continuous Intravenous Infusions of Growth Hormone-Releasing Factor l-44 NH2 (GRF-44) in Normal Men; Pituitary Responses and Pharmacokinetics.  VII Int. Congress of Endocrinology, 3 July 1984.  Excerpta Medical 652:605, 1984 (abstract 690).

 

13)  M.C. Gelato, S. Malozowski, M. Nicoletti, J.L. Ross, O.H. Pescovitz, D.L. Loriaux, and G.R. Merriam.  Responses to Growth Hormone-Releasing Hormone (GHRH) During Development and Puberty in Normal Boys and Girls.  Journees Internationales Henri-Pierre Klotz d'Endocrinologie Clinique, Paris, 30 May 1985.

 

14)  J. Winterer, S. Muzzo, S. Malozowski, I. Young, M. Gelato, F. Cassorla, and G. Merriam.  Growth Hormone Response to Growth Hormone Releasing Hormone (GHRH) Stimulation in Infantile Malnutrition Before and After Refeeding.  Journees Internationales Henri-Pierre klotz d'Endocrinologie Clinique, Paris, 31 May 1985.

 

15)  G.R. Merriam, M.C. Gelato, et al.  Applications of Growth Hormone-Releasing Hormone in Diagnosis and Therapy.  International Symposium: Challenges of Hypersecretion of GH.  Aegina, Greece, April 9, 1985, Neuroendocrinology Letters 7:102, 1985.

 

16)  E.P. Pavlov, S.M. Harman, G.R. Merriam, M.C. Gelato, and M.R. Blackman. Responses of Growth Hormone (GH) and Somatomedin-C (SmC) to Growth Hormone-Releasing Hormone (GHRH) in Healthy Aging Men.  The Endocrine Society, 19 June 1985.  Endocrinology 116:59A, 1985 (abstract 233).

 

17)  M.C. Gelato, S. Malozowski, M. Skerda, F. Cassorla, and G.R. Merriam.  Effects of Pulsatile Administration of Growth Hormone-Releasing Hormone in Linear Growth in Children with Growth Hormone Deficiency.  The Endocrine Society, 20 June 1985.  Endocrinology 116:123A, 1985 (abstract 491).

 

18)  S. Malozowski, M. Gelato, F. Cassorla, and G.R. Merriam.  Pulsatile Growth Hormone Releasing Hormone (GHRH) Treatment can Induce GH and Somatomedin-C Responses in GH Deficient (GHD) Children Initially Unresponsive to Single Bolus GHRH.  Society for Pediatric Research, May 1986.

 

19)  S. Malozowski, M. Caruso-Nicoletti, S. Rose, K. Hench,l J. Muir-Nash, F. Cassorla, G.R. Merriam, and M. Gelato.  GH-Releasing Hormone (GHRH) Therapy of Children with GH Deficiency: A Comparison of Infusion Pump and Manual GHRH Treatment Regimens.  The Endocrine Society, 27 June 1986.  Endocrinology 118:216A, 1986 (abstract 741).

 

20)  M.C. Gelato, L.A. Gaynes, L.A. Greenstein, S.P. Nissley.   Heterogeneity of Insulin-like Growth Factor (IGF) Binding Protein Species Derived from the Mr = 150K IGF-Binding Protein Complex.  Endocrinology 118:83A (abstract 208), 1986.

 

21)  O.H. Pescovitz, W. Wehrenberg, M.C. Gelato, D. Healy, M. Bundy, S. Seelig, and S.A. Berry.   Growth Hormone Releasing Hormone in Placenta and its Possible Role in Fetal Growth.  Endocrinology 122:86 (abstract 263) 1988.

 

22)  J. Vassalotti, H. Keiser, M.C. Gelato.  Insulin-like Growth Factor-II: Possible Local Growth Factor in Pheochromocytoma. American Federation for Clinical Research, 1989, Volume 37, 364A.

 

23)  D. Olchovsky, J.F. Bruno, M.C. Gelato, T.L. Wood, J.M. Gilbert, Jr, M. Berelowitz.  Altered Pituitary Growth Hormone Regulation in Diabetic Rats: A Combined Defect of Hypothalamic SRIF and GRF.  71st Annual Meeting of the Endocrine Society, Seattle, WA, June 1989, Abstract #40, p. 32.

 

24)  D.L. Blithe, S.R. Rose, M.C. Gelato, B.C. Nisula.  Evidence that TSH Oligosaccharide Branching is Different in Primary and Central Hypothyroidism.  71st Annual Meeting of the Endocrine Society, Seattle, WA, June 1989, Abstract #1827, p. 479.    

 

25)  E. Spatola, N.B. Johnson, O.H. Pescovitz, S.A. Berry, M.C. Gelato.  Growth Hormone Releasing Hormone (GHRH): A Possible Regulator of Placental and Fetal Insulin-like Growth Factors (IGFs).  72nd Annual Meeting of the Endocrine Society, Atlanta, GA, June 1990, Abstract #126, p. 56.

 

26)  D. Olchovsky, M.C. Gelato, J.F. Bruno, J. Song, M. Berelowitz.  Differential Regulation of IGF-I Gene Expression and Peptide Content in Pituitary and Liver of Diabetic Rats.  72nd Annual Meeting of the Endocrine Society, Atlanta, GA, June 1990, Abstract #1323, p. 355.

 

27)  D. Alexander, K. Marsh, M. Berelowitz, M. Gelato.  Differential Tissue Regulation of Insulin-like Growth Factor (IGF)-Binding Proteins (BPs) in Diabetes Mellitus.  2nd International IGF Symposium, San Francisco, CA, 1991, Abstract #D33, p. 301.

 

28)  D. Olchovsky, J.F. Bruno, J. Song, M. Gelato, M. Berelowitz.  Hypothalamic-Pituitary and Splanchnic Insulin-like Growth Factor-I (IGF-I) and IGF-I Receptor Expression in Food- Deprived Rats.  2nd International IGF Symposium, San Francisco, CA, 1991, Abstract #B15, p. 151.

 

29)  M.C. Gelato, K. Marsh, E. Spatola, J. Vassalotti, H.E. Carlson.  Differential Tissue Regulation and Discordant Expression of IGFs in Rats Bearing the MstT/W15 Pituitary Tumor.  73rd Annual Meeting of the Endocrine Society, Washington, DC, 1991, Abstract #1077, p.300.

 

30)  M.C. Gelato, M. Berelowitz, K. Marsh. Differential Tissue Regulation of Insulin-like Growth Factor-I in the Zucker Fatty Rat.  74th Annual Meeting of the Endocrine Society, San Antonio, Texas, 1992, Abstract #1171, p. 344.

 

31)  S. Castells, C. Torrado, M.C. Gelato. Growth Hormone (GH) Responses to GH-Releasing Hormone (GH-RH) Suggest Hypothalamic Dysfunction as a Cause for Growth Retardation in Down Syndrome (DS).  Society for Pediatric Research, 1991.

 

32)  S. Castells, I. Beaulieu, C. Torrado, K.E., Wisniewski, S. Zarny, M.C. Gelato. Hypothalamic Versus Pituitary Dysfunction in Down Syndrome (DS) As Cause for Growth Retardation.  International Conference on Growth Hormone Treatment in Down Syndrome, 1992.

 

33)  J. Fan, M.C. Gelato, P.E. Molina, N.N. Abumrad, C.H. Lang. Lipopoly Saccharide (LPS) Decreases Plasma Insulin-like Growth Factor (IGF)-I.  Sixteenth Annual Conference on Shock, Sante Fe, New Mexico, 1993.

 

34)  P.K. Manasco, D.L. Blithe, S.R. Rose, M.C. Gelato, J.A. Magner, B.C. Nisula. Thyroptropin Abnormalities in Central Hypothyroidism. Serono Meeting, 1994.

 

35)  J. Fan, P.E. Molina, M.C. Gelato, C.H. Lang. Regulation of Insulin-like Growth Factor (IGF)-I Content and Binding Proteins by Tumor Necrosis Factor (TNF).  Seventeenth Annual Conference on Shock.  Big Sky, Montana, June 1994.

 

36)  M.M. Wojnar, J. Fan, M.C. Gelato, C.H. Lang. Alterations in the Growth Hormone (GH)- Insulin-like Growth Factor (IGF)-Axis in Trauma Patients.  Seventeenth Annual Conference on Shock.  Big Sky, Montana, June 1994.

 

37)  H.E. Carlson, M. Graber, M.C. Gelato. Hormonal Effects of Erythropoietin Therapy in Hemodialysis.  76th Annual Meeting of the Endocrine Society, Anaheim, CA June 1994.

 

38)  R.A. Frost, C.H. Lang, J. Fuhrer, P.R. Mariuz, M.C. Gelato.  Abnormalities in the Serum Insulin-like Growth Factor (IGF) System During Human Immunodeficiency Virus (HIV) Associated Weight Loss. 76th Annual Meeting of the Endocrine Society. Anaheim, CA. June 1994.

 

39)  M.M. April, L. Jung, A. Heimann, M.C. Gelato. Follicular Variant of Papillary Carcinoma With Hyperthyroidism.  Annual Meeting of the Otolaryngology-Head and Neck, Surgery Society, 1994.

 

40)  P.E. Molina, J.Fan, C.H. Lang, M. Gelato, N.N. Abumrad. Thiamine Deficiency Regulates Growth Hormone and Insulin-Like Growth Factor-I System. ESPEN 1994 16th Congress and Scientific Meeting-Birmingham, United Kingdom, 31 August-2 September 1994.

 

41)  R.A. Frost, S. Nachman, J. Fuhrer, C.H. Lang, M.C. Gelato, Defects in the GH-IGF-I Axis of Adults With AIDS Wasting and Children Who Fail to Thrive. IGF Meeting Gainesville, Florida, 1995.

 

42)  M.C. Gelato, M. Sheehan, R. Frost, H.E. Carlson. Relationships Between IGFs, IGFBPs and DHEAS in Elderly Subjects. 77th Annual Meeting of the Endocrine Society. Washington, D.C.  June, 1995.

 

43)  M.C. Gelato, R.A. Frost, K. DeCristofaro, P.J. Garlick, C.H. Lang, R. Steigbigel, J. Fuhrer, M.A. McNurlan.  Growth Hormone (GH) Deficiency and Diminished Anabolic Responses in Muscle of HIV Infected Adults. 10th International Congress of Endocrinology, San Francisco, June 1996.

 

44)  R.A. Frost, S.A. Nachman, C.H. Lang, M.C. Gelato.  Proteolysis of IGFBP-3 in HIV Infected Children Who Fail to Thrive.  10th International Congress of Endocrinology, San Francisco, June 1996.

 

45)  M.A. McNurlan, P.J. Garlick, K. DeCristofaro, R.A. Frost, C.H. Lang, R. Steigbigel, J. Fuhrer, M.C. Gelato.  Growth Hormone (GH) Stimulates Albumin But Not Muscle Synthesis in HIV+ Individuals.  ESPEN, Geneva, September 8-11, 1996.

 

46)  R.A. Frost, C.H. Lang, M.C. Gelato.  Transient Exposure of Myoblast to Tumor Necrosis Faster (TNF) Selectively Inhibits Serum and Insulin-Like Growth Factor (IGF) Stimulated Protein Synthesis.  Presented at the 79^th Annual Meeting of The Endocrine Society, Minneapolis, MN 1997.

 

47)  D.C. Mynarcik, M.A. McNurlan, J. Quick, J. Fuhrer, R.T. Steigbigel, M.C. Gelato. Serum Markers of Metabolic Dysregulation in HIV Disease.  Presented at the 81^st Annual Meeting of the Endocrine Society, San Diego, CA, pg. 96, 1999.

 

48)  D.C. Mynarcik, M.A. McNurlan, R.T. Steigbigel, J. Brebbia, C. Brathwaite, J. Fuhrer, M.C. Gelato.  Elevated triglycerides and loss of limb fat are associated with a decrease in peripheral adipose tissue lipoprotein lipase gene expression.  Presented (oral) at the 82^nd Annual Meeting of the Endocrine Society, Toronto, Canada, 2000.

 

49)  S.A. Kho, L.K. Nieman, M.C. Gelato.  Cushings’ Disease After Surgery and Radiation Therapy For Non Functioning Pituitary Adenoma.  Presented at the 82nd Annual Meeting of the Endocrine Society, Toronto, Canada, 2000.

 

50)  D.C. Mynarcik, M. McNurlan, R. T. Steigbigel, J. Brebbia, C. Brathwaite, J. Fuhrer, M.C. Gelato.  Insulin Resistance in HIV Lipodystrophy is Associated with Increased Circulating TNF Receptor Levels but not Increased TNF Receptor Expression in Skeletal Muscle and Peripheral Fat.  Presented at the 2^nd Meeting of the Association for Patient Oriented Research, Arlington, VA, 2000.

 

51)  R. Bhasin, M.C. Gelato, J.L. Neus, M.A. McNurlan, D. C. Mynarcik.  The Abnormal Fat Distribution in HIV-Lipodystrophy Impacts on the GH/IGF Axis.  Presented at the 83^rd Annual Meeting of the Endocrine Society, Denver, CO, 2001.

 

52)  M. Gelato, D. Mynarcik, M. McNurlan.  Rosiglitazone Mediated Restoration of Subcutaneous Fat and Improvement in Insulin Sensitivity in HIV Associated Lipodystrophy.  Clinical Research Meeting, Baltimore, MD, 2002.  Oral presentation.

 

53)  Mynarcik, D.C., Combs, T.P., McNurlan, M.A., Scherer, P.E., and Gelato, M.C.  Rosiglitazone-mediated improvement in insulin sensitivity is highly correlated with increases in circulating Acrp30/Adiponectin in HIV-associated lipodystrophy.  Oral Presentation at the 84^th Annual Meeting of the Endocrine Society, San Francisco, CA, 2002.

 

54)  Mynarcik, D.C., Wei, L-X, Scherer, P.E., McNurlan, M.A., and Gelato, M.C.  Rosiglitazone increases the expression of PPAR-responsive genes in skeletal muscle in HIV-Lipodystrophy.  Oral Presentation at the 85th Annual Meeting of the Endocrine Society, Philadelphia, PA, 2003.

 

55)  Mynarcik, D.C. Wei, L-X, McNurlan, M.A., Gelato, M.C.  Subcutaneous fat loss in HIV-lipodystrophy is not associated with elevated apoptosis.  Oral Presentation at the 86^th Annual Meeting of the Endocrine Society, New Orleans, LA, 2004.

 

56)  Ferris, R.,McNurlan, M, Mynarcik, D.C., Kelly, P., Gelato, M.C. Chromium as a therapy for insulin resistance in HIV Disease: A Pilot Study. Clinical Research meetinds, Washington, D.C., April 2005.